Thalidomide alone or in combination with other agents for the treatment of myelodysplastic syndromes (MDS)

被引：2
|
作者：
Candoni, A.
Raza, A.
Galili, N.
Simeone, E.
Buttignol, S.
Silvestri, F.
Fanin, R.
机构：
[1] Univ Hosp, Div Hematol Bone Marrow Transplantat, Udine, Italy
[2] Univ Massachusetts, Med Ctr, Amherst, MA 01003 USA
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70214-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [32] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [33] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [34] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [35] COMBINATION OF ORAL RIGOSERTIB AND INJECTABLE AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Fenaux, P.
    Petrone, M.
    Zbyszewski, P.
    Fruchtman, S.
    Silverman, L.
    LEUKEMIA RESEARCH, 2017, 55 : S30 - S30
  • [36] Amifostine in combination with cytokines stimulates in vitro hemopoiesis in myelodysplastic syndromes (MDS).
    Rajapaksa, R
    Bhatia, S
    Swarnakar, A
    Kodali, U
    Greenberg, PL
    BLOOD, 1998, 92 (10) : 160B - 160B
  • [37] Cyclosporine a without or with thalidomide for the treatment of patients with Myelodysplastic syndromes.
    Xiao, Zhijian
    Xu, Zefeng
    Wang, Jianxiang
    Hao, Yushu
    BLOOD, 2007, 110 (11) : 222B - 222B
  • [38] Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 516 - 523
  • [39] The effectiveness of erythropoiesis stimulating agents (ESAs) in the treatment of myelodysplastic syndromes (MDS): Systematic Review and Meta Analysis
    Salek, S.
    Ngugi, N. M.
    Ehling, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 1006 - 1006
  • [40] A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes
    Wei, Wei
    Zhou, Fan
    Zhang, Yizi
    Guo, Lieping
    Shi, Haotian
    Hou, Jian
    LEUKEMIA RESEARCH, 2012, 36 (06) : 715 - 719
12345